Literature DB >> 7679839

Long-term insulin requirement after liver transplantation with FK 506 in American veterans.

J Tabasco-Minguillan1, L Mieles, P Carroll, J Gavaler, D H Van Thiel, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7679839      PMCID： PMC2965580     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

1.  Oral glucose tolerance test in liver recipients treated with FK 506.

Authors:  L Mieles; S Todo; J J Fung; A Jain; H Furukawa; M Susuki; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.

Authors:  V Scantlebury; R Shapiro; J Fung; A Tzakis; J McCauley; M Jordan; C Jensen; T Hakala; R Simmons; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.

Authors:  J Fung; K Abu-Elmagd; A Jain; R Gordon; A Tzakis; S Todo; S Takaya; M Alessiani; A Demetris; O Bronster
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 4.  Adverse effects associated with the use of FK 506.

Authors:  J J Fung; M Alessiani; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; D Van Thiel; J Armitage; A Jain; J McCauley
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

Authors:  J J Fung; S Todo; A Tzakis; A Demetris; A Jain; K Abu-Elmaged; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

Authors:  L Mieles; R D Gordon; D Mintz; R M Toussaint; O Imventarza; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Current status of FK 506 in liver transplantation.

Authors:  J J Fung; S Todo; A Tzakis; M Alessiani; K Abu-Elmagd; A Jain; O Bronster; M Martin; R Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-06       Impact factor: 1.066

8.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

9.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

10.  One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.

Authors:  S Todo; J J Fung; A Tzakis; A J Demetris; A Jain; M Alessiani; S Takaya; R Day; R Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066
View more
  1 in total

Review 1.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.